NCT05149274View on ClinicalTrials.gov

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Phase 1 Study, Healthy Volunteers
Interventions
DRUG

DWP14012 Tablet A

DWP14012 10mg

DRUG

DWP14012 Tablet B

DWP14012 40mg

Trial Locations (1)

Unknown

Bundang CHA Medical Center, Seongnam-si

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY